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Abstract
Background: Behavioral stress is recognized as a main risk factor for neuropsychiatric diseases. Converging evidence
suggested that acute stress is associated with increase of excitatory transmission in certain forebrain areas. Aim of this work
was to investigate the mechanism whereby acute stress increases glutamate release, and if therapeutic drugs prevent the
effect of stress on glutamate release.
Methodology/Findings: Rats were chronically treated with vehicle or drugs employed for therapy of mood/anxiety
disorders (fluoxetine, desipramine, venlafaxine, agomelatine) and then subjected to unpredictable footshock stress. Acute
stress induced marked increase in depolarization-evoked release of glutamate from synaptosomes of prefrontal/frontal
cortex in superfusion, and the chronic drug treatments prevented the increase of glutamate release. Stress induced rapid
increase in the circulating levels of corticosterone in all rats (both vehicle- and drug-treated), and glutamate release increase
was blocked by previous administration of selective antagonist of glucocorticoid receptor (RU 486). On the molecular level,
stress induced accumulation of presynaptic SNARE complexes in synaptic membranes (both in vehicle- and drug-treated
rats). Patch-clamp recordings of pyramidal neurons in the prefrontal cortex revealed that stress increased glutamatergic
transmission through both pre- and postsynaptic mechanisms, and that antidepressants may normalize it by reducing
release probability.
Conclusions/Significance: Acute footshock stress up-regulated depolarization-evoked release of glutamate from
synaptosomes of prefrontal/frontal cortex. Stress-induced increase of glutamate release was dependent on stimulation
of glucocorticoid receptor by corticosterone. Because all drugs employed did not block either elevation of corticosterone or
accumulation of SNARE complexes, the dampening action of the drugs on glutamate release must be downstream of these
processes. This novel effect of antidepressants on the response to stress, shown here for the first time, could be related to
the therapeutic action of these drugs.
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Introduction
Behavioral stress is recognized as a main risk factor for many
diseases, including cardiovascular, metabolic and neuropsychiatric
diseases. Among the latter, stress interacts with variable genetic
background of vulnerability in pathogenesis of mood/anxiety
disorders [1]. Exposure of rodents to various stress protocols
produces many behavioral, neurochemical, neuroendocrine, con-
comitants observed in humans [2–4]. While animals subjected to
chronic stress paradigms are often used as models of psychiatric
pathology, it is also important to study the brain response to acute
stress, because this may be particularly helpful in dissecting the
molecular and cellular mechanisms involved [5]. Acute stress
induces rapid changes in the release of neurotransmitters, hormones
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stress response is inadequate or excessive. Inappropriate stress
response acts as a trigger, which may produce a vulnerable
phenotype in genetically predisposed individuals and increase the
risk for mental ilness [2,3]. There is to date a lack of data on the
management of acute stress and on possible treatments that may
alleviate the distressing acute symptoms and prevent damaging
long-term consequences [6]. It should also be considered that the
effects of chronic stress are not simply an extrapolation of the effects
of acute stress, and complex adaptive phenomena must be taken
into account in the long run.
A number of studies have suggested that acute stress is
associated with increased excitatory amino acid transmission in
areas of the forebrain. Restraint stress, tail pinch, forced
swimming, footshock, and anxiogenic drugs have been shown to
increase the efflux of glutamate as measured by microdialysis in vivo
[7–9]. However, although it is assumed that behavioral stressors
can deeply affect homeostasis of glutamate transmission, it is not
yet clear:
1. What is the effect of acute stress on exocytotic release of
glutamate in limbic/cortical areas. Thus far this has been
assessed mainly or exclusively by in vivo microdialysis. However,
it has been argued that extracellular glutamate and GABA, as
measured by microdialysis, do not fulfill the classical criteria for
exocytotic release (tetrodotoxin sensitivity, calcium-dependen-
cy). Accordingly, a large portion of amino acid neurotransmit-
ters measured by this way may be of non-neuronal origin and
possibly carrier-mediated or derived from glial metabolism
[10]. Independent evidence (not from microdialysis) would be
helpful to verify the outcome of acute stress on glutamate
release and transmission.
2. What are the mechanisms whereby acute stress modifies
glutamate release. Recent work has shown that stress rapidly
increases the level of circulating stress-hormones and that in
hippocampus (HPC) corticosterone (CORT) binds to mem-
brane mineralocorticoid receptors (MR), which may rapidly
induce the release of glutamate through non-transcriptional
mechanisms [11,12]. It is not known at present what changes in
the mechanisms regulating glutamate release are affected by
CORT.
3. What is the effect of psychotropics used for therapy of
psychiatric disorders on the release of glutamate. A few studies
have suggested that chronic antidepressant treatments reduce
glutamate release in limbic/cortical areas in basal conditions
[13–15]. In particular, we have found previously that chronic
antidepressants reduce (K
+)depolarization-evoked release of
endogenous glutamate from synaptic terminals of HPC, with
concomitant modifications in protein-protein interactions
regulating assembly of the presynaptic SNARE (soluble N-
ethylmaleimide-sensitive fusion protein attachment protein
receptor) complex, that mediates fusion of synaptic vesicles,
and reduction of complexes in presynaptic membranes [13,16].
Here we found that acute footshock (FS)-stress up-regulates
depolarization-evoked exocytotic glutamate release in prefrontal/
frontal cortex (P/FC) but not HPC, by increasing the circulating
levels of CORT, stimulating glucocorticoid receptors (GR) in P/
FC, and inducing accumulation of SNARE complexes in
presynaptic membranes. Moreover, analysis of excitatory postsyn-
aptic currents (EPSCs) in pyramidal neurons of the prefrontal
cortex (PFC), showed that stress induced dramatic changes in
paired-pulse facilitation (PPF) and a slowdown of the EPSC
kinetics, suggestive of both pre- and postsynaptic actions. Previous
chronic administration of different antidepressants completely
prevented the stress-induced up-regulation of glutamate release by
a mechanism downstream of the elevation of CORT and SNARE
complex accumulation, which involves a decrease in release
probability.
Results
Depolarization-evoked release of glutamate from P/FC
synaptosomes is increased after acute footshock stress
Immediately after the FS-stress session, the synaptosomes were
purified from HPC and P/FC. Basal and 15 mM KCl-evoked
release of endogenous glutamate and GABA were measured from
synaptosomes in superfusion, the method of choice for the analysis
of neurotransmitter release from a single family of nerve terminals,
as described previously [13,17–19]. We have previously shown
that glutamate release measured by this way is essentially
exocytotic, dependent on external calcium and independent on
the function of membrane glutamate transporter [13].
Basal release of amino acid neurotransmitters from synapto-
somes, as well as depolarization-evoked release of GABA, were
unchanged in stressed rats (both areas) (Fig. 1A–B). Instead, acute
stress exerted different effects on depolarization-evoked glutamate
release in the two areas. While in HPC there were no changes, in
P/FC depolarization-evoked overflow of glutamate was markedly
and significantly increased in stressed rats (52%; p,0.05, Student’s
t test). This result was in line with previous findings of
microdialysis studies [7–9,20], and suggested that acute FS-stress
selectively increases the release of glutamate (but not of GABA) in
P/FC, and does not affect glutamate release in HPC.
Chronic antidepressant treatments dampen the increase
of glutamate release from P/FC synaptosomes induced
by footshock stress
We have shown previously that chronic treatments with
different antidepressants reduce depolarization-evoked release of
glutamate from HPC synaptosomes in basal conditions [13]. We
asked here whether these drugs may also dampen the increase of
glutamate release induced by acute stress in P/FC. We carried out
two distinct cycles of treatments employing four different drugs
(see Methods). In both studies, after 14 days of treatment with
vehicle or drug, each rat group was randomly divided in two
groups that were subjected to FS-stress, or sham-stressed (controls).
As shown in Fig. 2A–D, contrary to our previous results in HPC
[13], in P/FC none of the drugs significantly reduced depolariza-
tion-evoked glutamate release in the absence of stress. In both
studies acute FS-stress induced a marked and significant increase
in glutamate release (from 35–46%). Interestingly, the stress-
induced increase in glutamate release was completely prevented in
rat groups previously treated with each of the four drugs. One-way
ANOVA showed significant effects in both study 1 (F3,20=6,419,
p,0.01 in the fluoxetine [FLX] group [Fig. 2A] and F3,27=3.951,
p,0.01 in the desipramine [DMI] group [Fig. 2B]) and study 2
(F3,17=6.726, p,0.01 in the venlafaxine [VFX] group [Fig. 2C]
and F3,31=6.405, p,0.01 in the agomelatine [AGO] group
[Fig. 2D]). No effect of either stress or drug treatments on GABA
release was observed.
The increase of glutamate release induced in P/FC by
footshock stress is dependent on release of
corticosterone and activation of glucocorticoid receptor
Compelling evidence has shown that rapid effects of stress on
glutamate transmission and its plasticity in HPC are mediated by
Stress and Glutamate Release
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binding of CORT to membrane-located MR receptors [11,12].
Here the levels of CORT were rapidly elevated in serum after FS-
stress (Fig. 3A–B), whether rats were treated with antidepressants or
not (F3,15=37,40; p,0.0001 in study 1 and F3,33=56,59;
p,0.0001 in study 2) (for absolute CORT levels, see Tab. S1).
Thissuggeststhat:(i)chronicantidepressanttreatments donotblock
stress-induced rise of CORT, as found previously [21,22, but see
also ref. 23); (ii) the site of action of antidepressants in the
modulation of stress-induced glutamate release is downstream of
CORT release. In order to assess whether in P/FC the increase of
glutamate release is dependent on the binding of CORT to
receptors, we treated the rats with RU 486, a selective antagonist of
GR, or RU 28318, a selective antagonist of MR, both administered
30 min beforethe stresssession (50 mg/kg s.c.; Fig.3C–D). RU 486
completely prevented the increase of glutamate release induced
by FS-stress, with a significant effect of RU 486 (F1,12=10,81;
p,0.01) and a significant interaction between RU 486 and stress
(F1,12=19,37; p,0.001) (Fig 3C). No significant effects were found
for RU 28318 and RU 28318/stress interaction, with only
significant effect of stress (F1,12=20.91; p,0.001) (Fig. 3D). These
results suggested that in P/FC FS-stress dependent up-regulation of
glutamate release is mediated by increased CORT release and
increased stimulation of membrane GR.
The increase of glutamate release induced in P/FC by
footshock stress is accompanied by accumulation of
SNARE complexes in the presynaptic membrane
Similar to other cortical areas, glutamatergic neurons and
synapses are predominant in P/FC, amounting to up to 80% of
total synapses [16]. Moreover, we have shown here that FS-stress
significantly increased glutamate release but did not change the
release of GABA in P/FC. For these reasons molecular findings
observed in presynaptic machinery can be correlated to functional
findings (e.g., glutamate release) as done previously [13]. First, we
measured the general expression of the SNAREs (synaptobrevin,
syntaxin-1 and SNAP-25, the three proteins forming the core
exocytotic SNARE complex) as well as their levels in synapto-
somes; no changes were found in all rat groups (not shown).
Second, we investigated the effect of drug treatments (without
stress) on presynaptic SNARE complexes. We have shown
previously that in HPC antidepressant-induced reduction of
glutamate release is accounted for by changes in protein-protein
interactions regulating the assembly of the SNARE complex [13],
and by reduction of complex accumulation in presynaptic
membranes [16]. However, we found here that the drug
treatments did not modify the key interaction syntaxin-1/Munc-
18 in P/FC (Fig. S1, see Methods S1). The SNARE complex is
SDS-resistant and can be visualized by loading in SDS-PAGE
samples of purified presynaptic membranes treated at 25uC
instead of 100uC, performing Western blot with antibody for
syntaxin-1, and quantitating the complex by digital densitometry
[24–26]. Two major syntaxin-1-containing complexes, migrating
at ,100 kDa and ,80 kDa, were detected (Fig. S2A). First, we
measured SNARE complexes in drug-treated rats in basal
conditions (without stress); we found that in P/FC chronic
antidepressant treatments did not induce significant changes in
Figure 1. Basal and depolarization-evoked release of amino
acid neurotransmitters from synaptosomes after acute foot-
shock stress. A) Basal and 15 mM KCl evoked glutamate release from
hippocampal (HPC) and prefrontal/frontal cortex (P/FC) synaptosomes
of vehicle-treated (control, CNT) and subjected to acute footshock (FS)-
stress (2/+ Stress) rats. Data are expressed as means6SEM. *p,0.05,
two-tailed Student’s t test). Open bars, basal release; filled bars, 15 mM
KCl evoked release (n=4–6 rats/group). B) Basal and 15 mM KCl evoked
GABA release from HPC and P/FC synaptosomes of vehicle-treated
(CNT) and subjected to FS-stress (2/+ Stress) rats. Data are expressed as
means6SEM. Open bars, basal release; filled bars, 15 mM KCl evoked
release.
doi:10.1371/journal.pone.0008566.g001
Stress and Glutamate Release
PLoS ONE | www.plosone.org 3 January 2010 | Volume 5 | Issue 1 | e8566the amount of SNARE complexes (Fig. S2), in line with the
lack of changes in depolarization-evoked glutamate release (see
Fig. 2A–D).
Instead, FS-stress induced rapid and significant changes in the
amount of SNARE complexes, in line with the rapid increase of
glutamate release (Fig. 4). The stress induced accumulation of
100 kDa complexes in presynaptic membranes of P/FC, whether
the rats were pretreated or not with antidepressants (Fig. 4A,C,E,G)
(F3,26=6.286; p,0.01 in study 1 and F3,50=10.09; p,0.0001 in
study 2). As observed above for raised CORT levels, these results
would suggest that: (i) chronic antidepressant treatments do not
block the stress-induced accumulation of SNARE complexes; (ii)the
Figure 2. Effect of chronic antidepressant treatments on depolarization-evoked release of amino acid neurotransmitters from
prefrontal/frontal cortex synaptosomes. A) 15 mM KCl evoked glutamate and GABA release from P/FC synaptosomes of vehicle-treated (CNT),
chronically treated with fluoxetine (FLX), subjected to FS-stress (STRESS) or chronically treated with FLX and then subjected to FS-stress (FLX+STRESS)
rats. Data are expressed as means6SEM. *p,0.05, Newman-Keuls post-hoc tests following one-way ANOVA (n=6–9 rats/group). B) 15 mM KCl
evoked glutamate and GABA release from P/FC synaptosomes of vehicle-treated (CNT), chronically treated with desipramine (DMI), subjected to FS-
stress (STRESS) or chronically treated with DMI and then subjected to FS-stress (DMI+STRESS) rats. Data are as in A. *p,0.05, statistics as above. C)
15 mM KCl evoked glutamate and GABA release from P/FC synaptosomes of vehicle-treated (CNT), chronically treated with venlafaxine (VFX),
subjected to FS-stress (STRESS) or chronically treated with VFX and then subjected to FS-stress (VFX+STRESS) rats. Data are as in A. *p,0.05;
**p,0.01, statistics as above. D) 15 mM KCl evoked glutamate and GABA release from P/FC synaptosomes of vehicle-treated (CNT), chronically
treated with agomelatine (AGO), subjected to FS-stress (STRESS) or chronically treated with AGO and then subjected to FS-stress (AGO+STRESS) rats.
Data are as in A. **p,0.01, statistics as above.
doi:10.1371/journal.pone.0008566.g002
Stress and Glutamate Release
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glutamate release in P/FC is downstream of SNARE complex
formation.
Footshock stress increases glutamatergic transmission
with a dual mechanism and chronic desipramine
treatment normalizes it by decreasing release probability
The results of the experiments above showed that acute stress
rapidly increases the release of glutamate from freshly isolated P/
FC synaptic terminals. However, in order to understand whether
the same applies to whole tissue, where in vivo circuitry is
preserved, we carried out patch-clamp recordings from slices
obtained from rats subjected to the same FS-stress paradigm.
Spontaneous activity was recorded in pyramidal neurons of layer
III of the rat PFC during 15 min periods and EPSCs evoked by
spontaneous action potentials (sEPSCs) were selected as currents
.15 pA (Fig. 5A). Pyramidal neurons from acutely stressed rats
displayed a significant increase in sEPSC amplitude with respect to
control neurons (Fig. 5B,C), in the absence of significant effects on
sEPSC frequency (D=0.14; p.0.1; Kolgomorov-Smirnov test;
Fig. 5D). Such effect was virtually abolished by previous chronic
treatment with the antidepressant DMI (F3,33=4.474 for the
stress- DMI interaction, p,0.05), which was totally ineffective in
non-stressed rats (Fig. 5B,C). Cumulative analysis of sEPSC
amplitude (Fig. 5B) confirmed that the amplitude distribution of
sEPSCs in pyramidal neurons from stressed rats was significantly
different from all the other experimental groups (D=0.23,
p,0.0001 and D=0.21, p,0.0001 vs control and DMI+stress
groups, respectively; Kolgomorov-Smirnov test).
In order to explain the stress-induced increase in sEPSC
amplitude, which could be contributed by an increase in the
number of the release sites and/or in release probability, PPF was
assessed by recording EPSCs evoked by pairs of stimuli applied at
increasing interpulse intervals (Fig. 6A). In control neurons, the
analysis of the paired-pulse ratio (PPR) of the second to the first
eEPSC revealed a clear synaptic facilitation which peaked at short
interpulse intervals (Fig. 6B). In contrast to control neurons,
pyramidal neurons from acutely stressed rats displayed markedly
decreased PPRs, suggesting an increase in release probability.
Interestingly, such effect of acute stress was completely
abolished by chronic treatment of the rats with the antidepressant
DMI, which was virtually ineffective in the absence of stress. The
results indicate that acute stress strongly enhances the neurotrans-
mitter release probability, an effect that is fully normalized by
antidepressant pretreatment. To obtain further support to this
hypothesis, we estimated the sensitivity of PPR to increasing
concentrations of external Ca
2+ (Fig. 6A,C). In line with the above-
mentioned results, neurons from stressed rats showed a markedly
lower sensitivity to the changes in the external Ca
2+ concentration
than neurons from control rats, suggesting that the release
probability of stressed neurons already reached saturation at
physiological Ca
2+ concentrations. Moreover, the pretreatment
with DMI, ineffective in the absence of stress, completely restored
the Ca
2+ sensitivity of the PPR in neurons from stressed rats to
values similar to control rats.
Inspection of the shape of EPSCs also revealed a clear
slowdown of the kinetics in pyramidal neurons from stressed rats
(see, e.g. Figs 5A and 6A). A kinetic analysis of the rise and decay
times of eEPSCs revealed that stress significantly increased both
the rise (Fig. 6D,E) and the decay (Fig. 6D,F) times of eEPSCs.
However, in contrast with the effects on PPR and eEPSC
amplitude, chronic pretreatment with DMI was unable to
counteract the effect of stress on both parameters (F3,38=0.001,
p=0.98 and F3,37=0.177, p=0.73 for the stress-DMI interaction
in the rise and decay times, respectively). Such stress-induced
changes in EPSC kinetics strongly suggest a postsynaptic change in
glutamate receptors which was not targeted by DMI.
Discussion
Acute footshock stress up-regulates glutamate release in
prefrontal/frontal cortex by rapid elevation of
corticosterone and activation of glucocorticoid receptor
A main finding of the present work was an independent
evidence that acute behavioral stress up-regulates stimulation-
Figure 3. The increase of glutamate release induced in P/FC by
footshock stress is dependent on release of corticosterone and
activation of glucocorticoid receptor. A) Corticosterone serum
levels in vehicle-treated (CNT), subjected to FS-stress (STRESS) and
chronically treated with FLX or DMI and then subjected to FS-stress
(FLX+STRESS; DMI+STRESS) rats. Data are expressed as means6SEM.
*** p,0.001 vs CNT, Newman-Keuls post-hoc tests following one-way
ANOVA (n=5 rats/group). B) Corticosterone serum levels in vehicle-
treated (CNT), subjected to FS-stress (STRESS) and chronically treated
with VFX or AGO and then subjected to FS-stress (VFX+STRESS;
AGO+STRESS) rats. Data are expressed as means6SEM. *** p,0.001 vs
CNT, Newman-Keuls post-hoc tests following one-way ANOVA (n=10
rats/group). C–D) Depolarization evoked glutamate release from P/FC
synaptosomes of vehicle-treated (CNT) and subjected to FS-stress
(STRESS) rats pretreated or not with RU 486 (C), a selective antagonist of
glucocorticoid receptor or RU 28318 (D), a selective antagonist of
mineralocorticoid receptor. Data are expressed as means6SEM.
**p,0.01 and ***p,0.001, Bonferroni post-hoc tests following two-
way ANOVA (n=4 rats/group).
doi:10.1371/journal.pone.0008566.g003
Stress and Glutamate Release
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have been previously obtained by a number of microdialysis
studies in different areas [7–10], independent evidence is scanty.
The present results clearly showed with different tecniques that
depolarization-dependent release of glutamate is selectively up-
regulated by acute stress with respect to GABA release.
A number of previous studies have shown that the effects of
acute stress on glutamate release are mediated by raised levels of
CORT [20,27,28]. Moreover, recent work has shown that acute
stress may rapidly increase the level of circulating CORT that, by
binding to membrane-located MR and rapid non-transcriptional
action, induces the release of glutamate in HPC [11,12,29].
Several lines of evidence support the existence of membrane-
located G protein-coupled receptors for glucocorticoids in brain,
as shown for estrogen receptors [30]. In the present work we
obtained evidence that acute stress induces a rapid rise of CORT
levels, and that the potentiating effect of CORT on glutamate
release in P/FC is mainly mediated by a GR, similar to recent data
obtained in PFC with different stressors [31]. However, a
participation of MR receptor to this effect of acute stress cannot
be completely excluded; similarly, due to the time required to
prepare and superfuse the synaptosomes, it is possible that
transcriptional effects are also involved here. Interestingly, we
found that previous chronic treatment with different antidepres-
sants did not prevent the stress-induced CORT rise in serum, as
shown previously [21,22].
Mechanisms for the stress-induced up-regulation of
glutamate release and transmission
The presynaptic SNARE complex, consisting of a parallel four-
helix bundle formed by the SNARE motifs of the three neuronal
SNAREs, represents the core of machinery regulating transmitter
release [32–34]. Previous evidence has shown that the number of
SNARE complexes can be increased by chemical treatment of
synaptosomes, suggesting a correlation between the accumulation
of complexes and the number of vesicles available for release [25].
Moreover, kindling, a model of epileptogenesis associated with
sustained enhanced release of glutamate, induces long-term
Figure 4. The increase of glutamate release induced in P/FC by acute footshock stress is accounted for by accumulation of SNARE
complexes in presynaptic membranes of prefrontal/frontal cortex. A) Representative SNARE complexes of P/FC synaptosomes of vehicle-
treated (CNT), subjected to FS-stress (STRESS) and chronically treated with FLX or DMI and then subjected to FS-stress (FLX+STRESS and DMI+STRESS)
rats. B) Quantitation of syntaxin-1 in the rat groups as in (B). Data are expressed as means6SEM. C) Quantitation of normalized 100 kDa SNARE
complex. Data expressed as above. Each single SNARE complex was normalized on monomeric syntaxin-1 in the same lane. **p,0.01 vs CNT,
Newman-Keuls post-hoc tests following one-way ANOVA (n=6–8 rats/group). D) Quantitation of normalized 80 kDa SNARE complex. E)
Representative SNARE complexes of P/FC synaptosomes of vehicle-treated (CNT), subjected to FS-stress (STRESS) and chronically treated with
venlafaxine (VFX) or agomelatine (AGO) and then subjected to FS-stress (VFX+STRESS and AGO+STRESS) rats. F) Quantitation of syntaxin-1 in the rat
groups as in (F). Data expressed as above. G) Quantitation of normalized 100 kDa SNARE complex. *p,0.05 vs CNT, ***p,0.001 vs CNT; Statistics as
above (n=8–12 rats/group). H) Quantitation of normalized 80 kDa SNARE complex. ***p,0.001 vs CNT; Statistics as above.
doi:10.1371/journal.pone.0008566.g004
Stress and Glutamate Release
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[26]. The present results are in line with this previous evidence,
and suggest a mechanism whereby acute stress up-regulates
release, possibly by increasing the RRP of glutamatergic vesicles.
Interestingly, SNARE complexes were found to be increased in
frontal cortex of suicide schizophrenic and depressed individuals
[35]. If these data in humans will be confirmed, they will
strengthen the idea that excitatory transmission is altered in some
psychiatric diseases, and suggest a correlation between cellular/
molecular effects of stress and related findings in pathology
[3,36–40].
Patch-clamp recordings of pyramidal neurons in the PFC
revealed that FS-stress induces a significant increase of the sEPSC
amplitude associated with a strong decrease in synaptic facilitation.
Such results implicate an increase in release probability in the
stress enhancement of the sEPSCs amplitude. This hypothesis is
further confirmed by the flat Ca
2+-dependence of PPF in stressed
rats, which indicates that the release probability is already
saturated at physiological Ca
2+ concentrations. On the other
hand, the parallel slowdown of both the rise and the decay phases
of eEPSCs suggest that a postsynaptic mechanism is also involved
in the stress-induced enhancement of glutamatergic transmission.
Thus, the data indicate that the effects of stress are two-sided:
stress increases glutamate release by increasing the number of
SNARE complexes and the probability of release, and also affects
the kinetic properties of postsynaptic glutamate receptors. This
dual mechanism of action, by increasing the amount of released
neurotransmitter and extending the duration of postsynaptic
currents, produces a net increase in the depolarizing charge
transfer.
The dampening action of antidepressants on
stress-induced glutamate release
Because previous evidence showed that chronic antidepressants
reduce glutamate release in basal conditions [13–15], we asked
here whether these drugs may also dampen the increased
glutamate release induced by acute stress. For the first time, we
found here that four different antidepressants completely abolished
the stress-induced up-regulation of glutamate release, suggesting
that this may be a relevant component of the therapeutic action of
drugs. Indeed, a dampening of glutamate release could improve
the signal to noise ratio, when it becomes compromised by
excessive neuronal activation and release due to the action of
stress. With regard to the mechanism of this drug effect, as
previously discussed [41], we suggest that this is linked to the lack
of desensitization of heteroreceptors for 5-HT and NA on
postsynaptic cells [42], such as glutamatergic neurons, in the face
of the increase in 5-HT- and NA-transmission induced by the
chronic treatment with monoamine reuptake inhibitors. For
agomelatine, because of its unique receptor profile, the effect on
glutamate release is possibly mediated by different mechanisms
related to either the melatonin receptor agonism [43] or the
5HT2C receptors antagonism [44], or by a possible synergy
between the two properties.
We found that all drug treatments employed here did not block
either elevation of circulating levels of CORT or accumulation of
SNARE complexes in presynaptic membranes, suggesting that the
dampening action of drugs on glutamate release must be on
pathways located downstream of these processes and/or on
alternative pathways.
Indeed, patch-clamp recordings revealed that DMI pretreat-
ment completely normalized the increase of the sEPSC amplitude
and the strong decrease in synaptic facilitation induced by FS-
stress, suggesting that the antidepressant counteracts the effect of
stress on glutamate release by decreasing the probability of release.
Interestingly, DMI was completely ineffective in preventing the
effects of stress on the kinetics of eEPSCs, likely occurring at
postsynaptic level. Thus, it is possible that DMI leads to a partial
prevention of the stress-induced effects, limiting its action at the
presynaptic level. We speculate that this action is mediated by
changes in the Ca
2+-triggered process that leads from primed
SNARE complexes to membrane fusion. It will be interesting to
analyze the interaction of different regulatory proteins with the
SNARE complex (e.g., synaptotagmin, complexin, a/b-SNAP,
NSF) and investigate whether any of these regulatory steps is
affected by the drug treatments.
Summary
In summary, we found that acute FS-stress induced a rapid
up-regulation of depolarization-evoked glutamate release in P/
FC, by increasing circulating CORT level, stimulation of GR by
CORT and rapid accumulation of presynaptic SNARE
complexes in synaptic membranes. Previous chronic treatment
with different antidepressants prevented the up-regulation of
glutamate release in P/FC, by a mechanism that must be
downstream of SNARE complex accumulation. Because anti-
depressant treatments modify the response to acute stress
(measured as glutamate release), we suggest that this mechanism
Figure 5. Acute footshock stress enhances the amplitude of
spontaneous EPSCs, and desipramine pretreatment complete-
ly counteracts this effect. A) Representative traces of EPSCs evoked
by spontaneous action potentials (sEPSCs) recorded in pyramidal
neurons of layer III of prefrontal cortex obtained from vehicle-treated
(CNT) (black trace) and subjected to FS-stress (Stress) (grey trace) rats. B)
Mean cumulative analysis of sEPSCs amplitude evaluated in vehicle-
treated (CNT) (n=11), subjected to FS-stress (Stress) (n=7), chronically
treated with DMI (DMI) (n=9) or chronically treated with DMI and then
subjected to FS-stress (DMI+Stress) (n=9) rats. Cumulative curves were
analyzed by using the Kolgomorov-Smirnov test; *p,0.0001 FS-stressed
rats vs all the other groups). C,D) Amplitude (C), and frequency (D) of
sEPSCs (means6SEM) recorded in neurons obtained from vehicle-
treated (CNT) (n=10), subjected to FS-stress (Stress) (n=7), chronically
treated with DMI (DMI) (n=8) and chronically treated with DMI and
then subjected to FS-stress (DMI+Stress) (n=9) rats. *p,0.05 Bonferroni
post-hoc tests following two-way ANOVA.
doi:10.1371/journal.pone.0008566.g005
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particularly when they are prescribed for the therapy of anxiety
disorders. It must be mentioned that, although benzodiazepines
are increasingly being substituted by antidepressants for the
therapy of anxiety, a known mechanism for this action is still
lacking.
Because recent developments have identified different sites of
regulationofglutamatetransmission aspotentialtargetsof pharmaco-
logical intervention in psychiatric disorders [16,37,40,45–48], the
study of the action of different psychotropics on the presynaptic
protein machinery could uncover additional targets for future
therapeutic approaches.
Figure 6. The synaptic facilitation and its Ca
2+-dependence are significantly reduced in footshock stressed rats and the effect is
efficiently prevented by desipramine pre-treatment. A) Specimen paired-pulse eEPSCs at increasing Ca
2+ concentrations were obtained in
vehicle-treated (CNT) and subjected to FS-stress (Stress) rats by stimulating layer V at a time interval of 50 ms and recording from pyramidal neurons.
B) The mean paired-pulse ratio (PPR) of the second to the first eEPSC in neurons from vehicle-treated (CNT) (closed squares; n=11), subjected to FS-
stress (Stress) (open circles; n=11), chronically treated with DMI (DMI) (closed triangles; n=9) and chronically treated with DMI and then subjectedt o
FS-stress (DMI+Stress) (open triangles; n=10) rats were plotted as a function of the inter-stimulus interval (from 10 to 250 ms). PPR, at all tested
intervals, were significantly lower in cells from FS-stressed rats than in neurons from all the other groups (*p,0.05, Bonferroni post-hoc tests
following two-way ANOVA). C) PPR calculated at 50 ms inter-stimulus interval clearly decreased with increasing Ca
2+ concentrations in neurons of
vehicle-treated (CNT) (n=6), chronically treated with DMI (DMI) (n=8) and chronically treated with DMI and then subjected to FS-stress (DMI+Stress)
(n=9) rats. On the contrary, neurons from FS-stress rats (n=6) showed a lower sensitivity to the changes in external Ca
2+ concentration (*p,0.05, FS-
stressed vs all the other groups, Bonferroni post-hoc tests following two-way ANOVA). D) Representative eEPSCs traces recorded in vehicle-treated
(CNT) (black trace) and subjected to FS-stress (Stress) (grey trace) rats, showing the rise and decay kinetics fitted by mono-exponential curves. E,F)
Rise (E), and decay (F) times (means6SEM) of eEPSCs estimated in neurons obtained from vehicle-treated (CNT) (n=11), subjected to FS-stress (Stress)
(n=11), chronically treated with DMI (DMI) (n=8) and chronically treated with DMI and then subjected to FS-stress (DMI+Stress) (n=8) rats. *p,0.05;
**p,0.01, Bonferroni post-hoc tests following two-way ANOVA.
doi:10.1371/journal.pone.0008566.g006
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Footshock stress procedure and drug treatments
All experimental procedures involving animals were performed
in accordance with the European Community Council Directive
86/609/EEC and were approved by Italian legislation on animal
experimentation (Decreto Ministeriale 124/2003-A). Sprague-
Dawley rats (170–200 gr) were used. The footshock (FS)-stress
protocol was performed essentially as previously reported [49],
(40-min FS-stress; 0.8 mA, 20 min total of actual shock with
random intershock length between 2–8 sec). The FS-stress box
was connected to a scrambler controller (LE 100-26, Panlab) that
delivers intermittent shocks to the metallic floor. Sham-stressed
rats (controls) were kept in the stress apparatus without delivering
of shocks. In some experiments, the rats were treated 30 min
before stress with RU 486, a selective antagonist of glucocorticoid
receptor (GR), or RU 28318, a selective antagonist of MR
(50 mg/kg s.c.; dissolved in dimethylsulfoxide or propylene glycol,
respectively).
The rats were treated chronically (14 days) with antidepressants
in two different studies. The drugs were administered for 2 weeks
because in previous studies we found that this time allows to
measure the drug-induced decrease in depolarization-evoked
release in hippocampus of naı ¨ve (non stressed rats), and the related
molecular changes [13,50]. Four different drugs were used because
each of them represents a different primary mechanism: FLX
(selective serotonin reuptake inhibitor), DMI (tricyclic antidepres-
sant), VFX (selective noradrenaline and serotonin reuptake
inhibitor), AGO (an altogether different mechanism, agonist for
MT1/MT2 melatonin receptors and antagonist for 5-HT2C
receptor). Study 1: fluoxetine (FLX; 10 mg/kg), or desipramine
(DMI; 10 mg/kg) were delivered in drinking water (vehicle). The
average water intake per day for each cage (two rats) was recorded
for 4 days before starting and throughout the treatment, and drug
solutions were changed every two days according to animals’
weight, as reported in previous studies [51,52]. Rats were subjected
to FS-stress 24 h after the last administration and killed thereafter.
HPC and the whole frontal lobe, referred to as P/FC were quickly
dissected on ice and processed. Study 2: venlafaxine (VFX; 10 mg/
kg i.p.), agomelatine (AGO; 40 mg/kg i.p.) or vehicle (hydro-
xyethylcellulose, 1%, 1 ml/Kg, i.p.) were administered at 5.00 pm
(2 h before the start of the dark cycle, 7 pm). Rats were subjected to
FS-stress 16 h after the last administration and killed. HPC and P/
FC were dissected as above.
Serum was prepared from trunk blood by centrifugation and
stored at 280uC. Measurement of serum CORT levels was
performed by a commercial kit (Corticosterone EIA kit, Immu-
nodiagnostic System, Boldon, UK).
Preparation of purified synaptosomes for glutamate/
GABA release and synaptic signaling
Purified synaptic terminals (synaptosomes) were prepared by
centrifugation on Percoll gradients [53], with minor modifications
[13], from fresh brain tissue. Purity of synaptosomes and other
subcellularfractionswascheckedbyelectronmicroscopy(notshown)
and by measuring subcellular distribution of protein markers, as
previously shown [50]. For release experiments, synaptosomes were
resuspendedinphysiologicalmediumwiththefollowingcomposition
(mM): NaCl, 125; KCl, 3; MgSO4,1 . 2 ;C a C l 2,1 . 2 ;N a H 2PO4,1 ;
NaHCO3, 22; glucose, 10 (aeration with 95% O2 and 5% CO2);
pH 7.2–7.4. For molecular experiments, synaptosomes were
resuspended in lysis buffer: 120 mM NaCl, 20 mM HEPES
pH 7.4, 0.1 mM EGTA, 0.1 mM DTT, containing 20 mM NaF,
5m MN a 2PO4, 1 mM Na2VO4,a n d2ml/ml of protease inhibitor
cocktail (Sigma-Aldrich, Milan, Italy). The synaptic membrane-
fraction was prepared as previously reported [50].
Glutamate and GABA release experiments
Aliquots of synaptosomes (about 100 mg protein) were layered
on microporous filters at the bottom of a set of parallel superfusion
chambers maintained at 37uC [17,18]. Superfusion was started at
a rate of 0.5 ml/min with standard medium aerated with 95% O2
and 5% CO2. After 36 min of superfusion, to equilibrate the
system, samples were collected according to the following scheme:
two 3-min samples (t=36–39 min and t=45–48 min; basal
outflow) before and after one 6-min sample (t=39–45 min;
stimulus-evoked release). A 90-sec period of stimulation was
applied at t=39 min, after the first sample has been collected.
Stimulation of synaptosomes was performed with 15 mM KCl,
substituting for equimolar concentration of NaCl. Fractions
collected were analysed for endogenous glutamate and GABA
content. Amino acid release was expressed as nmol/mg of protein.
The stimulus-evoked overflow was estimated by subtracting
transmitter content of the two 3-min samples (basal outflow) from
release evoked in the 6-min sample collected during and after the
depolarization pulse (stimulus-evoked release) [13]. Drug treat-
ment effects were evaluated by comparing the stimulus-evoked
overflow in drug-treated animals vs. that calculated in vehicle-
treated rats. Appropriate controls were always run in parallel.
Endogenous glutamate and GABA were measured by high
performance liquid chromatography analysis [13].
Measurement of SNARE complex in isolated presynaptic
membranes
For detection of SDS-resistant SNARE complexes, Western
blotting was performed on samples of electrophoresed presynaptic
membranes (non-boiled before gel loading) [24–26], incubating
PVDF membranes containing blotted proteins with monoclonal
antibodies for syntaxin-1 1:5000 (Sigma-Aldrich). The membranes
were incubated with anti-mouse secondary antibody 1:4000
(Sigma-Aldrich), and immunoreactive bands revealed with
ECL
TM (GE Healthcare, Italy). Membranes were immediately
exposed to Hyperfilm ECL
TM films (GE Healthcare), and images
acquired with the Quantity One software and GelDoc imaging
system (Bio-Rad Laboratories, Italy). All bands used were within
linear range of standard curves, and normalized for syntaxin-1
monomer levels in the same membrane. Standardization and
quantitation of digitalized images were performed with Quantity
One software (Bio-Rad).
Western analysis
Western analysis was carried out as previously described [13,50],
by incubating PVDF membranes, containing electrophoresed and
blotted proteins from either synaptic terminals or presynaptic
membranes, with monoclonal antibodies for syntaxin-1 1:8000
(Sigma-Aldrich), synaptobrevin 1:6000 (Synaptic System, Go ¨ttin-
gen, Germany), SNAP-25 1:8000 (Synaptic System) and b-actin
1:10000 (Sigma-Aldrich). Following incubation with peroxidase-
coupled secondary antibodies, protein bands were detected with
ECL
TM. Standard curves were obtained by loading increasing
amounts of samples on gels as previously described [50]. All protein
bands used were within linear range, and normalized for b-actin
level in the same membrane. Standardization was as above.
Electrophysiology
Electrophysiological experiments were performed on acute
slices of rats subjected to acute stress and/or pretreatment with
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drug tested in these experiments) was performed, brain slices were
prepared 24 h after the last administration. Coronal prefrontal
cortical slices were obtained from adult male rats as previously
described [54]. Whole-cell voltage-clamp recordings from neurons
were performed with glass pipettes (,5 MOhm), pulled from
borosilicate glass and filled with the following intracellular solution
(mM): 126 Kgluconate, 4 NaCl, 1 MgSO4, 0.02 CaCl2, 0.1
BAPTA, 15 C6H12O6, 5 HEPES, 3 ATP, 0.1 GTP. Layer III
pyramidal neurons in the dorsal part of the medial prefrontal
cortex were visualized with a 406 water immersion lens and an
infrared camera. Evoked excitatory postsynaptic currents
(eEPSCs) were induced in pyramidal neurons of layer III by
electrical stimulation of layer V with a bipolar electrode (test pulses
at 0.1 Hz, 0.2 ms duration, stimulus intensity fixed at 2/3 of
maximal eEPSCs amplitude). When required, solutions at various
Ca
2+ concentrations (0.5–4 mM) were obtained by compensating
the NaCl content of the standard recording solution. Voltage
clamp data were acquired by using the MultiClamp 700B
amplifier (Axon Instruments, Molecular Devices, Sunnyvale, CA,
USA) and the pClamp 9.2 software (Axon Instruments).
Rise and decay times of eEPSCs were calculated as the time
from baseline-to-peak and from peak-to-30% of the EPSC
amplitude, respectively. The amplitude and frequency of sEPSCs
were calculated using a peak detector function with a threshold
amplitude set at 5 pA and a threshold area at 20 ms*pA. To
analyze the paired-pulse ratio (PPR), afferent fibres were
stimulated by two brief supraliminar depolarizing pulses applied
at 10–250 ms intervals. For each eEPSC couple, PPR was
calculated from the equation PPR=I2/I1, where I2 and I1 are
the amplitudes of the second and first eEPSC, respectively.
Clampfit software was used to analyze eEPSCs.
Statistical analysis
Statistical analysis was carried out by the unpaired Student’s t
test when only two experimental groups were involved or by one-
way analysis of variance (ANOVA) followed by the Newman-
Keuls test for comparisons of data with more than two groups.
When the combined effects of stress and treatment were analyzed,
two-way ANOVA was used followed by the Bonferroni’s post-hoc
multiple comparison test. Statistical analysis of the data was
carried out using GraphPad Prism4 (GraphPad Software Inc.,
USA).
Statistical analysis of electrophysiological data was performed
with Origin 7.0 (OriginLab Corporation, Northampton, MA)
and Sigmastat (Systat Software Inc., Chicago, IL) softwares using
one- and two-way ANOVA followed by post-hoc multiple
comparison Bonferroni’s test. Cumulative curves were analyzed
by the Kolmogorov-Smirnov test using the R-CRAN Environ-
ment software (http://cran.r-project.org). Figures were edited
with Corel Draw 12 (Corel Corporation, Ottawa, Canada). For
all analyses a value of p,0.05 was considered statistically
significant.
Supporting Information
Table S1 Absolute corticosterone values (ng/ml) for measure-
ments reported in Fig. 3.
Found at: doi:10.1371/journal.pone.0008566.s001 (3.43 MB TIF)
Figure S1 Chronic antidepressant treatment did not modify
syntaxin-1/Munc-18 interaction in synaptic membranes of
prefrontal/frontal cortex. A) Munc-18 was immunoprecipitated;
Munc-18 and syntaxin-1 in the immunoprecipitate were analyzed
by Western analysis. Representative immunoreactive bands are
shown. CNT, Control; FLX, fluoxetine; DMI, desipramine. Data
represent the means6SEM (percentage ratio syntaxin-1/Munc-
18) of four separate experiments in duplicate. B) Munc-18 was
immunoprecipitated; Munc-18 and syntaxin-1 in the immunopre-
cipitate were analyzed by Western analysis. Representative
immunoreactive bands are shown. CNT, Control; VFX, venlafax-
ine; AGO, agomelatine. Data represent the means6SEM
(percentage ratio syntaxin-1/Munc-18) of four separate experi-
ments in duplicate.
Found at: doi:10.1371/journal.pone.0008566.s002 (0.79 MB TIF)
Figure S2 Chronic antidepressant treatment did not modify
SNARE complex levels in presynaptic membranes of prefrontal/
frontal cortex. A) Representative image of SNARE complexes in
synaptosomes visualized by Western blot with a monoclonal
antibody for syntaxin-1. The SNARE complex is maintained and
visualized only when synaptic membranes are loaded at 25A ˆuC
(25A ˆu input), while it is disassembled when the samples are heated
at 100A ˆuC before loading (100A ˆu input). The two SNARE
complex forms of approximately 100 and 80 kDa are indicated, as
well as the monomeric form of syntaxin-1. B) Representative
SNARE complexes in control rats (CNT) and rats chronically
treated with fluoxetine (FLX) or desipramine (DMI). C) Quanti-
tation of syntaxin-1 in the rat groups as in (B). Data are expressed
as means6SEM. D) Quantitation of normalized 100 kDa SNARE
complex. Data expressed as above. Each single SNARE complex
was normalized on monomeric syntaxin-1 in the same lane (n=8
rats/group). E) Quantitation of normalized 80 kDa SNARE
complex. F) Representative SNARE complexes in control rats
(CNT) and rats chronically treated with venlafaxine (VFX) or
agomelatine (AGO). G) Quantitation of syntaxin-1 in the rat
groups as in (F). Data expressed as above. H) Quantitation of
normalized 100 kDa SNARE complex. Statistics as above (n=8
rats/group). I) Quantitation of normalized 80 KDa SNARE
complex. Statistics as above.
Found at: doi:10.1371/journal.pone.0008566.s003 (4.62 MB TIF)
Methods S1
Found at: doi:10.1371/journal.pone.0008566.s004 (0.04 MB
DOC)
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